RheumaVision 2026: Meet the Finalists
Jun 23, 202622m
🎧 Hear from RheumaVision 2026 finalists Vilde Øverlien Dåstøl, Kabir Budlender, and Mariia Sobchenko as they reflect on their projects, inspirations, and hopes for the future of rheumatology.
Hosted by Unknown Host · 🇺🇸 US · EN · 70 episodes
Established thought leaders with verified media credentials.
Welcome to the EMEUNET podcast. A place for educational rheumatology content to improve research and patient care, offered by the EMerging EUlar NETwork (EMEUNET, find out more at emeunet.eular.org)
Unknown Host hosts EMEUNET Podcast, a health show with 70 episodes published.
🎧 Hear from RheumaVision 2026 finalists Vilde Øverlien Dåstøl, Kabir Budlender, and Mariia Sobchenko as they reflect on their projects, inspirations, and hopes for the future of rheumatology.
Inside Rheumavision Join Olivier in conversation with Cristiana Sieiro Santos and two semi-finalists from the second edition of Rheumavision 2026.
🎧 Want to get involved in EULAR Task Forces? In the latest #EMEUNET Podcast, Olivier, Luis & Renske break down: ✔️ What a Task Force is ✔️ Who’s involved ✔️ How YOU can join
Join Renske Meijer & Milena Bond as they bring patients and healthcare professionals together to share perspectives that matter. Plus, Sophia Marantidou speaks with Dr Jean-Guillaume Letarouilly and Prof Claire Daien abo
Learn about the new EULAR Classification Criteria for Haemochromatosis Arthropathy — a key step forward for research and clinical practice.
Join Renske, Rudi, and Olivier for a special episode of the EMEUNET podcast—a quiz-style episode highlighting key rheumatology publications from 2025. Fun, interactive, and packed with take-home messagesyou won’t want to
This week we dive into the Peer Review Programme — what it is, how it works, and why it matters for early-career rheumatologists.
Join Olivier & Guillermo as they speak with 3 winners of the EMEUNET Top 10 Abstracts Hear from: 🔹 Lilla Gunkl-Tóth 🔹 Kensuke Suga 🔹 Carlo Tur
In this special EULAR Young PARE & EMEUNET Joint Podcast episode for World Arthritis Day 2025, themed “Achieve Your Dreams!”, we explore the hopes and aspirations of people living with rheumatic and musculoskeletal disea
"Young and ambitious" – Renske chats with Dr. Luis Coronel, a passionate rheumatologist from Barcelona. Discover how he helped shape the EULAR ultrasound courses and what drives his journey!
Join Renske & Olivier as they talk with Prof. Flavia Ciccutini about repurposing metformin for patients with overweight or obesity. 🔍 Challenges, insights & future research!
Join Olivier, Rudi & Pierre as they chat with 3 winners of the EMEUNET Top 10 Abstracts!
Recorded at #EULAR2025, Olivier chats with Jean-Guillaume Letarouilly and the Rheumavision winners about creativity, science communication, and what this experience meant to them.
Join Rudi and Pierre in the latest #EMEUNETPodcast as they shine a light on the emerging and fast-growing field ofcardio-rheumatology.
Renske chats with Cristiana Seiero Santos, Jean-Guillaume Letarouilly & Tue Kragstrup, the visionaries behind #Rheumavision. Learn about its foundation — and join the final event at #EULAR2025!
Join Gozde and Oliver as they talk with Prof. Denis Poddubnyy about the ASAS consensus definition of difficult-to-manage axSpA. Get a behind-the-scenes look at how this definition was developed, the challanged faced, and
Come along and join Barbara and Renske as they have a really great talk with Dr Nikiphorou about the connection between nutrition and RMDs, key research findings, and how all of this relates to the clinic.
Join Renske and Olivier as they test your knowledge of reproductive rheumatology in this special episode. They will be joined by Prof. Radboud Dolhain from Erasmus MC, Rotterdam, who will share his expertise on the subje
Join Olivier and Pierre and hear from 3 winners of the EMEUNET Top 10 Abstracts! Listen to Jacob Koopman, Johannes Knitza and Andreas Kerschbaumer to find out more about their work and their experience of the ACR Converg
Join Barbara and Pierre and hear from Dr. Bryant England, Associate Professor of the University of Nebraska who investigates RA-ILD in the Veterans Affairs RA registry. Learn about his effort to use such valuable dataset
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch EMEUNET Podcast, visit https://podcasters.spotify.com/pod/show/emeunet-podcast for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent health coverage.
EMEUNET Podcast is hosted by Unknown Host. The show is categorised under health (fitness) and has published 70 episodes.
EMEUNET Podcast has published 70 episodes.
EMEUNET Podcast regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
EMEUNET Podcast is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
EMEUNET Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of EMEUNET Podcast average 26 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates EMEUNET Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 10 days ago.